Abstract
Bone mineral density (BMD) at lumbar spine (L2-L4) was measured by dual-energy X-ray absorptiometry (DEXA) in 21 children with predialysis chronic renal failure (CRF) and 44 children with end-stage renal failure (ESRF) on regular hemodialysis. BMD results were expressed as Z-scores. Osteopenia was documented in 13 predialysis patients (61.9%) and 26 patients (59.1%) with ESRF. No significant correlation was observed between Z-scores and the duration of CRF or estimated creatinine clearance. In osteopenic children there was a negative correlation between Z-scores and serum phosphorus (r=−0.61, P=0.004), intact parathyroid hormone (iPTH) (r=−0.47, P=0.03), and bone-specific alkaline phosphatase (r=−0.52, P=0.02) and a positive correlation with total calcium (r=0.41, P=0.07) and 25-hydroxycholecalciferol (r=0.53, P=0.02). Osteopenic children who had iPTH values ≥200 pg/ml were more osteopenic than those who had lower iPTH levels (P=0.006). In conclusion, osteopenia, assessed by DEXA, is frequent in children with CRF. It occurs early irrespective of the duration or the severity of CRF. In children with ESRF the degree of osteopenia is correlated with laboratory markers of renal osteodystrophy and patients with biochemical findings of secondary hyperparathyroidism are more osteopenic than the others.
Similar content being viewed by others
References
Llach F, Coburn JW (1989) Renal osteodystrophy and maintenance dialysis. In: Maher JF (ed) Replacement of renal function by dialysis. Kluwer, Dordrecht, pp 911–952
Malluche H, Faugere MC (1990) Renal bone disease. An unmet challenge for the nephrologists. Kidney Int 38:193–211
Christiansen C (1995) Osteoporosis: diagnosis and management today and tomorrow. Bone 17:513S–516S
Ruedin P, Rizzoli R, Sloman D, Leski M, Bonjour JP (1994) Effects of oral calcitriol on bone mineral density in patients with end-stage renal failure. Kidney Int 45:245–252
Przedlacki J, Manelius J, Huttunen K (1995) Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure. Nephron 69:433–437
Boot AM, Nauta J, Jong MC de, Groothhoff JW, Lilien MR, Wijk JA van, Kist-van Holthe JE, Hokken-Koelega AC, Pols HA, Muinck Keizer-Schrama SM de (1998) Bone mineral density, bone metabolism and body composition of children with chronic renal failure with and without growth hormone treatment. Clin Endocrinol (Oxf) 49:665–672
Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic failure. Kidney Int 56:1084–1093
Tall MW, Masud T, Green D, Cassidy DMJ (1999) Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 14:1922–1928
Gerakis A, Hadjidakis D, Kokkinaks E, Aposto T, Raptis S, Billis A (2000) Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol 13:437–443
Ziolkowska H, Panczyk-Tomaszewska M, Majkowska Z, Rajkowski T, Debinski A, Przedlacki J, Sawicki A, Ostrowski K, Marcinski A, Roszkowska-Blain M (2001) Imaging of bone in the diagnosis of renal osteodystrophy in children with chronic renal failure. Med Sci Monit 7:1034–1042
Pluskiewicz W, Adamczyk P, Drozdzowska B, Szprynger K, Szczepanska M, Halaba Z, Karasek D (2003) Skeletal status in children and adolescents with chronic renal failure before onset of dialysis or on dialysis. Osteoporos Int 14:283–288
Pluskiewicz W, Adamczyk P, Drozdzowska B, Szprynger K, Szczepanska M, Halaba Z, Karasek D (2002) Skeletal status in children, adolescents, and young adults with end-stage renal failure treated with hemo- or peritoneal dialysis. Osteoporos Int 13:353–357
Groothoff JW, Offringa M, Van Eck-Smit BL, Gruppen MP, Van de Kar NJ, Wolff ED, Lilien MR, Davin JC, Heymmans HS, Dekker FW (2003) Severe bone disease and low bone mineral density after juvenile renal failure. Kidney Int 63:266–275
Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590
Hamady NAT (1995) The spectrum of renal bone disease. Nephrol Dial Transplant 10 [Suppl 4]:14–18
Gonzalez EA, Martin KJ (1995) Renal osteodystrophy: pathogenesis and management. Nephrol Dial Transplant [Suppl 3]:13–21
Malluche H, Monier-Faugere CM (1992) Risk of adynamic bone disease in dialyzed patients. Kidney Int 42 [Suppl 38]:S62–S67
Eechout E, Verbeelen D, Sennesael J, Kaufman L, Jonckeer MH (1989) Monitoring of bone mineral content in patients on regular hemodialysis. Nephron 52:158–161
Lechleitner P, Krimbacher E, Genser N, Fridrich L, Nedden D zur, Helweg G, Koenig P, Joannidis M (1994) Bone mineral densitometry in dialysed patients: quantitative computed tomography versus dual photon absorptiometry. Bone 15:387–391
Wittich A, Vega E, Casco C (1996) Ultrasound measurement of the tibia in chronic hemodialysis patients. J Bone Miner Res 11 [Suppl 1]:S247
Chao SH, Tsai KS, Chieng PU, Lee PH, Lee CJ, Lee CS (1994) Bone mineral density profile in uremic and renal transplant patients. Transplant Proc 26:2009–2011
Copley JB, Hui SL, Leapman S, Slemenda CW, Johnston CC (1993) Longitudinal study of bone mass in end-stage renal disease patients: effects of parathyroidectomy for renal osteodystrophy. J Bone Miner Res 8:415–422
Urena P, Bernad-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, Vernejoul MC de (2003) Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18:2325–2331
Atsumi K, Kushida K, Yamazaki K, Shimmizu S, Ohmura A, Inoue T (1999) Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287–293
Nilsson P, Melsen F, Malmaeus J, Danielson BG, Mosekilde L (1985) Relationships between calcium and phosphorus homeostasis, parathyroid hormone levels, bone aluminum, and bone histomorphometry in patients on maintenance hemodialysis. Bone 6:21–27
Delmas PD, Malaval L, Arlot ME, Meunier PJ (1985) Serum bone gla-protein compared to bone histomorphometry in endocrine diseases. Bone 6:329–341
Delmas PD, Demiaux B, Malaval L, Chapuy MC, Edouard C, Meunier PJ (1986) Serum bone gla-pro-tein (osteocalcin) in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry. J Clin Invest 77:985–991
Bataille R, Delmas PD, Sany J (1987) Serum bone gla-protein in multiple myeloma. Cancer 59:329–334
Schonau E (1988) Problems of bone analysis in childhood and adolescence. Pediatr Nephrol 12:420–429
Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45:253–258
Minisola S, Rosso R, Romagnoli E, Pacitti MT, Scarnecchia L, Carnevale V, Mazzuoli G (1993) Trabecular bone mineral density in primary hyperparathyroidism: relationship to clinical presentation and biomarkers of skeletal turnover. Bone Miner 20:113–123
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bakr, A.M. Bone mineral density and bone turnover markers in children with chronic renal failure. Pediatr Nephrol 19, 1390–1393 (2004). https://doi.org/10.1007/s00467-004-1670-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-004-1670-2